TY - CHAP M1 - Book, Section TI - Obstructive and Nonobstructive Coronary Disease in Heart Failure A1 - Lee, Charlotte A1 - Dec, G. William A2 - Fuster, Valentin A2 - Narula, Jagat A2 - Vaishnava, Prashant A2 - Leon, Martin B. A2 - Callans, David J. A2 - Rumsfeld, John S. A2 - Poppas, Athena Y1 - 2022 N1 - T2 - Fuster and Hurst's The Heart, 15e AB - Content UpdateStudy Summary: REVIVED-BCIS2The Revascularization for Ischemic Ventricular Dysfunction (REVIVED-BCIS2) trial was a prospective, multicenter, open-label trial that randomized 700 patients with left ventricular dysfunction (defined as left ventricular ejection fraction (LVEF) of ≤35%), extensive coronary artery disease amenable to percutaneous coronary intervention (PCI), and demonstrable myocardial viability to a strategy of optimal medical therapy (OMT) plus PCI (n=347) or OMT alone (n = 353). Read More SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/04 UR - accesscardiology.mhmedical.com/content.aspx?aid=1202454909 ER -